SU2C Lung Cancer Dream Team Launches Website for KRAS-positive Lung Cancer Patients

LUNGevity presented the team’s newly launched website, a patient-centric resource that enables users to be active, informed participants in their diagnosis and treatment, at a poster session at the 2016 Stand Up to Cancer (SU2C) Scientific Summit.
According to the company press release:

[President Andrea Ferris, a member of the Stand Up to Cancer Lung Cancer Dream Team] is an advocacy representative on the Lung Cancer Dream Team, created in April 2015 to address treatment options for patients with KRAS-mutant lung cancer. She helped create the patient-friendly website and guided its December launch. The resource will help patients understand their disease and treatment options, report on the Lung Cancer Dream Team’s research progress, and inform patients of open clinical trials.

Jeffrey Engelman, MD, PhD, member of the Lung Cancer Dream Team’s Scientific Research team commented:

While there have been meaningful steps forward in lung cancer research, treatments for patients with the KRAS mutation have seen little success. To be successful, it’s crucial that our team connect the science to the patient, and connect the patient to the science through enrollment in clinical trials.  We can’t accomplish these goals without advocates who ensure that the patient voice and needs are incorporated.

Click here to view the full press release.